Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 8, 2012, Pages 1311-1320

  Hunsawong, Taweewun ^a   Singsuksawat, Ekapot ^b   In Chon, Nuannapa ^a   Chawengrattanachot, Watinee ^a   Thuwajit, Chanitra ^b   Sripa, Banchob ^a   Paupairoj, Anucha ^a   Chau In, Siri ^a,c   Thuwajit, Peti ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cholangiocarcinoma; Estrogen; Invasion; TFF1 trefoil protein

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GROWTH FACTOR; TAMOXIFEN; TREFOIL FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER CELL CULTURE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN BLOOD LEVEL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TFF1 GENE;

ADULT; AGED; ALKALINE PHOSPHATASE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIRUBIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHOLANGIOCARCINOMA; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERUM ALBUMIN; SURVIVAL ANALYSIS; TAMOXIFEN; TUMOR SUPPRESSOR PROTEINS;

EID: 84864331022     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1207-1     Document Type: Article

References (42)

1. Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P, Ginanni-Corradini S, Onetti Muda A, Dostal DE, De Santis A, Attili AF, Benedetti A, Gaudio E (2006) Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol 169(3):877-888 (Pubitemid 44411954)
2. Bagi CM, Wood J, Wilkie D, Dixon B (2008) Effect of 17bhydroxysteroid dehydrogenase type 2 inhibitor on bone strength in ovariectomized cynomolgus monkeys. J Musculoskelet Neuronal Interact 8(3):267-280
3. Bengochea L, Ouviña G, Lemberg A (1985) Liver microsomal bilirubin UDP-glucuronyltransferase disturbances in bile duct ligated rats. Biochem Biophys Res Commun 130(1):163-167 (Pubitemid 15249014)
4. Caiazza F, Galluzzo P, Lorenzetti S, Marino M (2007) 17b-estradiol induces ERb up-regulation via p38/MAPK activation in colon cancer cells. Biochem Biophys Res Commun 359(1):102-107 (Pubitemid 46839219)
5. Cavanaugh J, Niewoehner CB, Nuttall FQ (1990) Gynecomastia and cirrhosis of the liver. Arch Intern Med 150(3):563-565 (Pubitemid 20122009)
6. Charbel H, Al-Kawas FH (2011) Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep 13(2):182-187
7. Chen J, Robertson G, Field J, Liddle C, Farrell GC (1998) Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats. Hepatology 28(3):624-630 (Pubitemid 28405407)
8. Flamini MI, Sanchez AM, Genazzani AR, Simoncini T (2011) Estrogen regulates endometrial cell cytoskeletal remodeling and motility via focal adhesion kinase. Fertil Steril 95(2):722-726
9. Fukushima S, Okuno H, Shibatani N, Nakahashi Y, Seki T, Okazaki K (2008) Effect of biliary obstruction and internal biliary drainage on hepatic cytochrome P450 isozymes in rats. World J Gastroenterol 14(16):2556-2560 (Pubitemid 352037746)
10. Harada N, Ota H, Yoshimura N, Katsuyama T, Takagi Y (1998) Localized aberrant expression of cytochrome P450 aromatase in primary and metastatic malignant tumors of human liver. J Clin Endocrinol Metab 83(2):697-702 (Pubitemid 28496561)
11. Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves WS, Rochefort H (1998) Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer 75(4):654-658 (Pubitemid 28094116)
12. Hennessy BA, Harvey BJ, Healy V (2005) 17b-Estradiol rapidly stimulates c-fos expression via the MAPK pathway in T84 cells. Mol Cell Endocrinol 229(1-2):39-47 (Pubitemid 40018081)
13. Hoffmann W (2005) Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci 62(24):2932-2938 (Pubitemid 43004746)
14. Isse K, Specht SM, Lunz JG III, Kang LI, Mizuguchi Y, Demetris AJ (2010) Estrogen stimulates female biliary epithelial cell interleukin- 6 expression in mice and humans. Hepatology 51(3):869-880
15. Kendler M, Makrantonaki E, Tzellos T, Kratzsch J, Anderegg U, Wetzig T, Zouboulis C, Simon JC (2010) Elevated sex steroid hormones in great saphenous veins in men. J Vasc Surg 51(2): 639-646
16. Kida N, Yoshimura T, Mori K, Hayashi K (1989) Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7). Cancer Res 49(13):3494-3498 (Pubitemid 19178164)
17. Kumar A, Klinge CM, Goldstein RE (2010) Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors a and b. Int J Oncol 36(5): 1067-1080
18. Liossi AK, Aroni KG, Kyrkou KA, Kittas C, Markaki SP (1988) Immunohistochemical study of sex steroid hormones in primary liver cancer. Cancer Detect Prev 13(3-4):195-201
19. Liu ZH, He YP, Qin H (2010) The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939. Mol Biol Rep 37(6): 2693-2701
20. Mancino A, Mancino MG, Glaser SS, Alpini G, Bolognese A, Izzo L, Francis H, Onori P, Franchitto A, Ginanni-Corradini S, Gaudio E, Alvaro D (2009) Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. Dig Liver Dis 41(2):156-163
21. Musgrove EA, Sutherland RL (2009) Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9(9): 631-643
22. Narasaka T, Moriya T, Endoh M, Suzuki T, Shizawa S, Mizokami Y, Matsuoka T, Sasano H (2000) 17b-hydroxysteroid dehydrogenase type 2 and dehydroepiandrosterone sulfotransferase in the human liver. Endocr J 47(6):697-705 (Pubitemid 32118483)
23. Olivo-Marston SE, Mechanic LE, Mollerup S, Bowman ED, Remaley AT, Forman MR, Skaug V, Zheng YL, Haugen A, Harris CC (2010) Serum estrogen and tumor-positive estrogen receptor-a are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women. Carcinogenesis 31(10):1778-1786
24. Prest SJ, May FE, Westley BR (2002) The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB J 16(2):592-594
25. Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J, Tiwari RK (2010) Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20(1):33-41
26. Rio MC, Chambon P (1990) The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Cancer Cells 2(8-9):269-274
27. Rodrigues S, Nguyen QD, Faivre S, Bruyneel E, Thim L, Westley B, May F, Flatau G, Mareel M, Gespach C, Emami S (2001) Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptordependent signaling pathways. FASEB J 15(9):1517-1528 (Pubitemid 32673381)
28. Sampson LK, Vickers SM, Ying W, Phillips JO (1997) Tamoxifenmediated growth inhibition of human cholangiocarcinoma. Cancer Res 57(9):1743-1749 (Pubitemid 27199669)
29. Sasaki M, Tsuneyama K, Nakanuma Y (2003) Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab Invest 83(10):1403-1413 (Pubitemid 37267824)
30. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24(2):115-125 (Pubitemid 38738341)
31. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST (2010) Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 101(3):579-585
32. Spillman MA, Manning NG, Dye WW, Sartorius CA, Post MD, Harrell JC, Jacobsen BM, Horwitz KB (2010) Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis. Cancer Res 70(21):8927-8936
33. Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, Puapairoj A, Sripa C, Miwa M (2005) Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 11(22):3392-3397 (Pubitemid 40873244)
34. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS (2004) Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) a or ERb in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 145(7):3473-3486 (Pubitemid 38830020)
35. Thim L (1997) Trefoil peptides: from structure to function. Cell Mol Life Sci 53(11-12):888-903 (Pubitemid 28021502)
36. Thuwajit P, Chawengrattanachot W, Thuwajit C, Sripa B, May FE, Westley BR, Tepsiri NN, Paupairoj A, Chau-In S (2007) Increased TFF1 trefoil protein expression in Opisthorchis viverrini-associated cholangiocarcinoma is important for invasive promotion. Hepatol Res 37(4):295-304 (Pubitemid 46505844)
37. Wallace AE, Gibson DA, Saunders PT, Jabbour HN (2010) Inflammatory events in endometrial adenocarcinoma. J Endocrinol 206(2):141-157
38. Weichselbaum RR, Hellman S, Piro AJ, Nove JJ, Little JB (1978) Proliferation kinetics of a human breast cancer line in vitro following treatment with 17b-estradiol and 1-b-D-arabinofuranosylcytosine. Cancer Res 38(8):2339-2342 (Pubitemid 8390875)
39. Yamaguchi Y, Hayashi S (2009) Estrogen-related cancer microenvironment of breast carcinoma. Endocr J 56(1):1-7
40. Yio X, Diamond M, Zhang JY, Weinstein H, Wang LH, Werther L, Itzkowitz S (2006) Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 130(6):1696-1706 (Pubitemid 43668862)
41. Yu L, Wang CY, Shi J, Miao L, Du X, Mayer D, Zhang J (2011) Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Endocrinology 152(3):773-781
42. Zhu H, Zheng J, Xiao X, Zheng S, Dong K, Liu J, Wang Y (2010) Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells. Oncol Rep 23(1):129-139